Clinical Trials on Coronavirus Disease 2019 (COVID-19) in Finland
Total 101 results
-
Veru Inc.CompletedSARS-CoV InfectionUnited States, Argentina, Brazil, Bulgaria, Colombia, Mexico
Sponsors and Collaborators
- Vaxxinity, Inc.
- Etablissement Publique de Santé Mentale de la Réunion
- Pyrotech Therapeutics, Inc.
- Institutos Nacionales de Salud, USA Instituto Alemán del Cáncer
- Jadran Galenski laboratorij d.d.Rijeka
- Ministry of Tourism, Sport and the Arts, British Columbia
- ViiV Healthcare Australia Pty. Ltd
- MRC/UVRI & LSHTM Uganda Research Unit
- Marta Camats Terre
- Medical School University of Zagreb
- Tianjin Medical University
- Centre de Pharmacologie Clinique, INSERM CIC 501
- Medtronic Poland Spółka z ograniczoną odpowiedzialnością
- PharmTest s.r.o.
- First Hospital Affiliated to Baotou Medical College, Baotou, China
- Uzès hospital
- Incept BioSystems, Inc.
- St. Louis Children's Hospital
- Diabetech
- CK-CARE (Christine Kühne - Center for Allergy Research and Education)
- View Full List
Medical Conditions
- Critical Illness Sepsis, Severe
- Vasomotor Symptoms Associated With Menopause
- Nonarthritic Hip Disease
- Post-Cerebrovascular Accident (CVA) Hemiparesis
- Human Papilloma Virus Infection
- Well-trained Athletes
- Breast Cancer Treatment
- Oral Allergic Syndrome
- Vomit
- Fenofibrate
- Native and Valve in Valve Aortic Valve Failure
- Pulpotomy of Young Permanent Molars
- Neoplasms, Advanced Solid
- High Turnover Bone Disease
- Repository Corticotropin Injection
- Family Functioning
- Hepatitis C, Treatment Naïve, Genotype 1 Patients
- Relapsed Malignant Solid Tumor
- Central Centrifugal Cicatricial Alopecia (CCCA)
- Non-sedentary
- View Full List
Drug Interventions
- Oxaliplatin
- ASP2151
- Famciclovir
- Lidocaine
- Carboplatin
- Phenelzine Sulfate
- SHR-1210
- Sulfasalazine
- Tamsulosin
- Keytruda
- 40 consecutive doses of SUF NT 15 mcg taken every 20 minutes
- Experimental DW224aa
- RoActemra sc
- SPLA2 Inhibitor
- Olorofim
- Prazosin
- Ropivacaine 0.2%
- Weak steroid (Flurolon, Allergan)
- 0.45% saline in 5% dextrose (intravenous)
- Durvalumab
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Angola
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Canada
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in India
- Contract Research Organizations in Israel
- Contract Research Organizations in Italy
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Vietnam
- CRO list by country